Publications by authors named "Viveca Ritsinger"

Claim this Profile
C
Cardiovascular disease and beta-cell function at diagnosis of serologically defined adult-onset type 1 and type 2 diabetes in two Swedish cohorts 15 years apart.
Viveca Ritsinger, Rebecka Gunnarsson, Eva Melin, Magnus Hillman, Anna Stogianni

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The recent renewed interest among cardiologists in detecting and preventing diabetes is welcomed.
Anna Norhammar, Viveca Ritsinger

Eur Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose co-transporter inhibitors-who would have guessed?
Anna Norhammar, Viveca Ritsinger

Lancet Diabetes Endocrinol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Impact of Obesity in Patients With Diabetes and Myocardial Infarction: A SWEDEHEART Registry Report.
Viveca Ritsinger, Bo Lagerqvist, Anna Norhammar

JACC Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease.
Viveca Ritsinger, Kamila Avander, Bo Lagerqvist, Pia Lundman, Anna Norhammar

Cardiovasc Diabetol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
Irene Santos-Pardo, Mikael Andersson Franko, Bo Lagerqvist, Viveca Ritsinger, Björn Eliasson

J Am Coll Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.
Viveca Ritsinger, Emil Hagström, Kristina Hambraeus, Stefan James, Tomas Jernberg

J Diabetes Complications· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study.
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson

BMJ Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
Robin Kristófi, Johan Bodegard, Viveca Ritsinger, Marcus Thuresson, David Nathanson

Cardiovasc Diabetol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.
Sara Meziani, Giulia Ferrannini, Mette Bjerre, Troels K Hansen, Viveca Ritsinger

Cardiovasc Diabetol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.
Viveca Ritsinger, Emil Hagström, Bo Lagerqvist, Anna Norhammar

J Am Heart Assoc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.
Irene Santos-Pardo, Bo Lagerqvist, Viveca Ritsinger, Nils Witt, Anna Norhammar

Int J Cardiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry.
Viveca Ritsinger, Bo Lagerqvist, Pia Lundman, Emil Hagström, Anna Norhammar

Diab Vasc Dis Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry.
Viveca Ritsinger, Thomas Nyström, Nawsad Saleh, Bo Lagerqvist, Anna Norhammar

Eur J Prev Cardiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study.
Viveca Ritsinger, Jens Jensen, Daniel Ohm, Elmir Omerovic, Sasha Koul

Diab Vasc Dis Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction.
Anne Wang, Stefan Arver, John Flanagan, Viveca Gyberg, Per Näsman, Viveca Ritsinger

Diab Vasc Dis Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.
Viveca Ritsinger, Kerstin Brismar, Linda Mellbin, Per Näsman, Lars Rydén

Diab Vasc Dis Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry Report.
Viveca Ritsinger, Christel Hero, Ann-Marie Svensson, Nawzad Saleh, Bo Lagerqvist

Diabetes Care· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Maria Isabel Smaradottir, Viveca Ritsinger, Viveca Gyberg, Anna Norhammar, Per Näsman

Diab Vasc Dis Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Viveca Ritsinger, Kerstin Brismar, Klas Malmberg, Linda Mellbin, Per Näsman

Diab Vasc Dis Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry.
Viveca Ritsinger, Nawsad Saleh, Bo Lagerqvist, Anna Norhammar

Circ Cardiovasc Interv· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Viveca Ritsinger, Eleni Tanoglidi, Klas Malmberg, Per Näsman, Lars Rydén

Diab Vasc Dis Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
Viveca Ritsinger, Klas Malmberg, Anton Mårtensson, Lars Rydén, Hans Wedel

Lancet Diabetes Endocrinol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis